Industry Briefs: May 7, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Briefs: May 7, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.


Company News

Almac has installed an Uhlmann high-speed blister line in its new US commercial packaging facility. Read More

Celsion has signed a long-term commercial-supply agreement with Zhejiang Hisun Pharmaceutical for the production of ThermoDox, a heat-activated liposomal encapsulation of doxorubicin. Read More

Evotec has signed a compound-management agreement with the US Environmental Protection Agency. The contract covers a period of five years and has a total value of up to EUR 7.7 million ($10 million). Read More

Grain Processing Corporation (GPC) has opened its new Solutions Center, located in the Technical Development Center at GPC headquarters in Muscatine, Iowa. Read More

Lorus Therapeutics and Genentech have signed a global intellectual property license agreement for IL-17E, a drug for treating cancer. Read More

Marina Biotech has announced a worldwide exclusive licensing agreement with Monsanto for Marina Biotech’s delivery and chemistry technologies. Read More

Pii has provided funding for hot-melt extrusion capabilities at the University of Mississippi. Read More

Sartorius Stedim Biotech and c-LEcta have signed a sales and distribution agreement for c-LEcta’s proprietary Serratia marcescens nuclease for biopharmaceutical applications. Read More

SGS Life Science Services has announced the availability of preformulation and formulation services at its laboratory in Lincolnshire, Illinois.

People News

Althea Technologies has appointed Kristin DeFife as director of biologics manufacturing and Jack Wright as vice-president of sales and marketing. Read More

Covance has announced several executive appointments. Read More

EMD Millipore has appointed Andrew Bulpin as head of the company’s process solutions business unit. Read More

GlaxoSmithKline named James Shannon chief medical officer, effective May 1, 2012. Read More

In other news, GlaxoSmithKline has appointed Lynn Elsenhans and Jing Ulrich to its board as nonexecutive directors, effective July 1, 2012. Read More

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
25%
Attracting a skilled workforce
31%
Obtaining/maintaining adequate financing
13%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here